UNC Lineberger’s Fellowship Program in Hematology/Oncology is being recognized by the American Society of Clinical Oncology (ASCO) this weekend at the organization’s annual meeting in Chicago, Illinois.
CHAPEL HILL, N.C. - The article "Why do men die earlier?" written by Bridget Murray-Law and published in the June 2011 issue of Monitor on Psychology, looks at new research that analyzes how men take care of themselves.
Dr. Stuart Gold is division chief of UNC Lineberger's pediatric hematology and oncology program.
LIVESTRONG® Survivorship Center of Excellence Network to Host Landmark Meeting on Survivorship Care and Advocacy in Response to 2011 Report Findings
Conference will be held in Washington, D.C., Sept. 15-16. UNC Lineberger Comprehensive Cancer Center is part of a collaborative effort among leading medical institutions brought together by LIVESTRONG.
Data will help scientists worldwide design better experiments.
University Cancer Research Fund updates, record poster session highlights of 2011 scientific retreat
The sixth annual UNC Lineberger scientific retreat drew a record number of posters – 68 – for the poster session and competition – and close to 150 people for the talks and reception.
Chapel Hill - Tacrolimus, a drug that is commonly used to prevent organ transplantation rejection, inhibits breast cancer growth in pre-clinical studies. The finding from UNC scientists was reported in the May 26th Public Library of Science.
Tom May used to donate blood, but not often. If he had it to do over, he’d give as much as possible. But he can’t.
CHAPEL HILL, N.C. – Carol Otey, PhD talks about the hope & health that has resulted from recent pancreatic research & collaboration on the May 14, 2011 broadcast of Here's to Your Health.
Chapel Hill - When cancer patients experience medical problems, they may visit emergency departments, but how often and for what reasons, there is little data.
A University of North Carolina at Chapel Hill study has joined the ranks of an elite group of programs recognized for their contributions to reducing cancer.
Innovative collaboration between physics and cell biology demonstrates pathway
Richard Goldberg, MD, distinguished professor and chief of the division of hematology/oncology, has been appointed to chair the 2012 Gastrointestinal Cancers Symposium Steering Committee on behalf of the American Society for Clinical Oncology (ASCO).
CHAPEL HILL, N.C. – Dr. Carolyn Sartor discussed the “New Life After Cancer” organization on the April 28, 2011 broadcast of Here's to Your Health. Dr. Sartor is a breast cancer survivor and former Chair of Radiation Oncology at UNC.
The 35th annual UNC Lineberger scientific symposium attracted more than 530 participants. Held at the Friday Center on April 27-28, 2011, the event featured speakers on "Cell Metabolism and Cancer."
NCCU-UNC Lineberger scientific collaboration yields new findings
Prestigious Executive Leadership in Academic Medicine Program builds pipeline of women leaders
CHAPEL HILL – Researchers at the University of North Carolina at Chapel Hill School of Medicine, after isolating normal stem cells that form the developing placenta, have given them the same properties of stem cells associated with an aggressive type of breast cancer.
Chapel Hill, NC - Samuel Cykert, MD, has received a $1.8 million five-year grant from the American Cancer Society (ACS) to study “Lung Cancer Surgery: Decisions Against Life Saving Care.”
The UNC-Mission Hospital Cancer Partnership, part of the UNC Cancer Network, welcomes Candace Cox, RN, OCN, to the program staff.
Local show features UNC Lineberger
A study of DNA rearrangements in roundworm chromosomes may offer new insight into large-scale genome duplications that occur in developing tumors.
UNC physician scientist receives National Academy of Sciences grant to develop cancer nanotechnology
New research from the University of North Carolina at Chapel Hill School of Medicine adds clarity to the connection. The study published on-line April 10th in the journal Nature Immunology finds that saturated fatty acids but not the unsaturated type can activate immune cells to produce an inflammatory protein, called interleukin-1beta.
"Tet is likely to be one of the important players for stem cell reprogramming."
Prestigious Breast Cancer Research Foundation-AACR Grant funds preclinical studies
CHAPEL HILL, N.C. - On Friday, March 11, a group of nurses gathered for a UNC Health Care Grand Rounds presentation by Jerome Schiro, RN, MN, OCN, Pat Decator, RN, BSN, OCN, and Amy De Pue, RN, BS, OCN.
CHAPEL HILL, N.C. - My Colon Cancer Coach, a new website that launched this week, serves as a tool to help people diagnosed with colon cancer.
UNC researchers working toward a rehabilitation road map
CHAPEL HILL, N.C. - The article "Next Generation Treatment for Triple-Negative and Basal-Cell Breast Cancer" written by Jonathan Batchelor and published on the website cancernetwork.com on March 9, 2011 features an interview with UNC Lineberger member Lisa Carey, MD.
CHAPEL HILL, N.C. - A UNC study released this week in the Journal of Clinical Oncology finds an increasing incidence of squamous cell carcinoma of the oral tongue in young white females in the United States over the last three decades.
C.A.R.E. Behind the Chair® program scheduled for May9
CHAPEL HILL, N.C. - Federico Innocenti, MD, PhD, has been appointed associate professor of pharmacy in the UNC Eshelman School of Pharmacy. He will serve as associate director of the UNC Institute for Pharmacogenomics and Individualized Therapy and a member of UNC Lineberger Comprehensive Cancer Center.
CHAPEL HILL, N.C. - A Triangle-based UNC spinoff company at the forefront of efforts to use nanotechnology to tackle diseases has received a $10 million investment from the Bill & Melinda Gates Foundation.